Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07203105 · ClinicalTrials.gov registry record · NA
GAINS Expert Guiding Technology to Coach Life Skill Teaching
A NA study of GAINS Expert Guiding Technology to Coach Life Skill Teaching, sponsored by Guiding Technologies Corporation.
- Recruiting
- Registry status
- NA
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT07203105: Recruiting NA study of GAINS Expert Guiding Technology to Coach Life Skill Teaching, sponsored by Guiding Technologies Corporation.
NCT07203105 is a NA study of GAINS Expert Guiding Technology to Coach Life Skill Teaching that is actively recruiting participants, run by Guiding Technologies Corporation. The registered enrollment target is 24 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07203105, a NA study of GAINS Expert Guiding Technology to Coach Life Skill Teaching, is actively recruiting participants, sponsored by Guiding Technologies Corporation.
- RECRUITING
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
Based on proven techniques in operant conditioning, the expert behavior guiding functionality in GAINS to teach life skills will be evaluated. Behavior practitioners will develop task analyses that break down complex life skills into simpler component steps and then enter these tasks into the GAINS system. In a similar way to navigation systems for drivers, GAINS will provide behavioral navigation for caregivers implementing ABA therapy programs. Using the GAINS app on a tablet or smartphone, caregivers will receive automatically updated visual and audio behavioral guidance, that includes what to do, when to do it, and detailed step-by-step guidance on how to execute ABA therapy programs.
Primary Outcome
The life skill steps (as determined by pre-treatment task analysis) the child performs without caregiver prompts divided by total life skill steps.
Conditions Studied
Interventions
- BEHAVIORAL GAINS expert guiding technology to coach life skill teaching
Study Locations (1)
Arkansas
- University of Arkansas - Fayetteville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2025-02-01 |
| Est. Completion | 2026-05-31 |
| Phase | NA |
What NCT07203105 shows while recruiting
NCT07203105 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 1 condition, with GAINS Expert Guiding Technology to Coach Life Skill Teaching appearing as the primary indexed condition, and to 1 intervention - of which GAINS expert guiding technology to coach life skill teaching is the first listed.
NCT07203105 reports a single indexed study location in Arkansas.
Frequently Asked Questions
What is clinical trial NCT07203105 about?
NCT07203105 is a clinical study titled "GAINS Expert Guiding Technology to Coach Life Skill Teaching". Based on proven techniques in operant conditioning, the expert behavior guiding functionality in GAINS to teach life skills will be evaluated. Behavior practitioners will develop task analyses that break down complex life skills into simpler component steps and then enter these tasks into the GAINS ...
What is the current status of trial NCT07203105?
This trial is currently recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2025-02-01. Estimated completion is 2026-05-31.
What conditions does trial NCT07203105 study?
This clinical trial studies the following conditions: GAINS Expert Guiding Technology to Coach Life Skill Teaching.
What interventions are being tested in trial NCT07203105?
The interventions under investigation include: GAINS expert guiding technology to coach life skill teaching (BEHAVIORAL).
Who is sponsoring clinical trial NCT07203105?
This trial is sponsored by Guiding Technologies Corporation, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07203105 being conducted?
This trial has 1 study location across Arkansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07203105's enrollment target sits among peer trials
24 1736th of 2000 higher than 246 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI